These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29422106)

  • 1. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.
    Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Rudat V; Schild SE
    Radiat Oncol; 2018 Feb; 13(1):21. PubMed ID: 29422106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.
    Rades D; Huttenlocher S; Šegedin B; Perpar A; Conde AJ; Garcia R; Veninga T; Stalpers LJ; Cacicedo J; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):368-72. PubMed ID: 26232852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
    Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
    Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
    Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
    Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression.
    Rades D; Veninga T; Conde-Moreno AJ; Cacicedo J; Metz M; Šegedin B; Norkus D; Rudat V; Schild SE
    Pract Radiat Oncol; 2017; 7(2):137-144. PubMed ID: 28274397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
    Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
    Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials.
    Rades D; Cacicedo J; Conde-Moreno AJ; Segedin B; Lomidze D; Ciervide R; Hollaender NH; Schild SE
    Radiat Oncol; 2021 Jan; 16(1):7. PubMed ID: 33413492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
    J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.
    Huttenlocher S; Sehmisch L; Rudat V; Rades D
    J Dermatol; 2014 Dec; 41(12):1082-6. PubMed ID: 25327333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial.
    Rades D; Conde-Moreno AJ; Cacicedo J; Šegedin B; Stanic K; Metz M; Rudat V; Schild SE
    Anticancer Res; 2018 Feb; 38(2):1009-1015. PubMed ID: 29374734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression.
    Rades D; Šegedin B; Conde-Moreno AJ; Ferrer-Albiach C; Metz M; Polat B; Badakhshi H; Schreiber A; Nitsche M; Cacicedo J; Schild SE
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):760-764. PubMed ID: 31415797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).
    Rades D; Šegedin B; Conde-Moreno AJ; Garcia R; Perpar A; Metz M; Badakhshi H; Schreiber A; Nitsche M; Hipp P; Schulze W; Adamietz IA; Norkus D; Rudat V; Cacicedo J; Schild SE
    J Clin Oncol; 2016 Feb; 34(6):597-602. PubMed ID: 26729431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
    J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
    Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
    Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic spinal cord compression from pancreatic cancer.
    Rades D; Huttenlocher S; Schild SE; Bartscht T
    Anticancer Res; 2014 Jul; 34(7):3727-30. PubMed ID: 24982394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
    Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
    J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.